Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» revusiran
revusiran
Alnylam review turns up no clear answers on revusiran deaths
BioPharma Dive
Thu, 08/10/17 - 06:53 pm
Alnylam
revusiran
RNAi
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Motley Fool
Sun, 12/4/16 - 12:37 pm
biotech
Alnylam
revusiran
Clovis Oncology
rociletinib
Celldex Therapeutics
Rintega
Eli Lilly
solanezumab
Novavax
RSV-F
Arrowhead
ARC-520
ARC-521
ARC-AAT
Biomarin
drisapersen
Alnylam Pharma stock plummets 45% after discontinuing drug on patient safety concerns
Marketwatch
Thu, 10/6/16 - 09:24 am
Alnylam
clinical trials
revusiran
Alnylam reports results from Phase 2 revusiran trial
Seeking Alpha
Fri, 11/14/14 - 09:54 am
Alnylam
revusiran
TTR cardiac amyloidosis
RNAi